Why Viking Therapeutics (VKTX) Stock Fell 8.3% on November 16, 2026
-8.28%$26.80November 16, 2026 · S&P 500 -1.91%
The short answer
Viking Therapeutics (VKTX) stock is down 8.3% today, trading at $26.80. This decline occurs despite the broader market, represented by the S&P 500 ETF (SPY), being down only 1.9%, indicating that the stock's move is primarily specific to VKTX or its industry. Recent headlines include a report on the company’s clinical trial results for VK2735, which indicated that 74% of participants improved their BMI category compared to 15% on placebo. While this news could be seen as positive, it does not seem to have mitigated the stock's decline today.
The news behind it
Before you buy or sell
Get a second opinion on VKTX
The bull case, the bear case and a verdict, with the numbers, in 10 seconds. Free →
Don't miss the next one
Alert me when VKTX moves
Price, RSI and volume alerts by email or push. Free plan →
Full market recap for November 16, 2026 · What's moving VKTX today
Written from that session's quote and the headlines listed above. Educational, not financial advice.